SCHEMBL1441018

SCHEMBL1441018

CC[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)CCN=C(N)S1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 17/20 0.63
BACE2 Q9Y5Z0 3/20 0.63
CTSD P07339 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1441003 0.91 BACE1 (0.54) BACE1BACE2CTSD
SCHEMBL1440516 0.91 BACE1 (0.52) BACE1BACE2CTSD
SCHEMBL1441138 0.89 BACE1 (0.54) BACE1BACE2CTSD
SCHEMBL1441215 0.88 BACE1 (0.49) BACE1BACE2CTSD
SCHEMBL1441022 0.88 BACE1 (0.52) BACE1BACE2
SCHEMBL1441073 0.87 BACE1 (0.52) BACE1BACE2CTSD
SCHEMBL1442061 0.87 BACE1 (0.67) BACE1BACE2CTSD
SCHEMBL1440658 0.87 BACE1 (0.67) BACE1BACE2CTSD
SCHEMBL1441242 0.86 BACE1 (0.50) BACE1BACE2
SCHEMBL1440706 0.84 BACE1 (0.58) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011029803-A1 2 -AMINODIHYDRO [1, 3] THIAZINES AS BACE 2 INHIBITORS FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-03-17 WO claimed
WO-2011029803-A1 2 -AMINODIHYDRO [1, 3] THIAZINES AS BACE 2 INHIBITORS FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-03-17 WO disclosed